©2018 by The Meisel and The Hinterleitner Lab. Proudly created with Wix.com

FUNDING & AWARDS

 

UPMC HILLMAN DEVELOPMENTAL FUNDING PROGRAM

Gut barrier dysfunction as risk factor for hematopoietic malignancies

2019 (1 year)

DDRCC UNIVERSITY OF CHICAGO PILOT & FEASIBILITY AWARD

2017 (1 year)

Define the role of TET2 mutations or deletion in intestinal barrier dysfunction and late-onset IBD

FWF ERWIN SCHRÖDINGER FELLOWSHIP (J3408)

Define the role of virus infections in loss of oral tolerance and celiac disease

2013-2015 (2 years)